Angela Mastaloudis,Steven M. Wood,Mark Bartlett,Shelly Hester
申请号：
US15253710
公开号：
US20180055802A1
申请日:
2016.08.31
申请国别(地区):
US
年份:
2018
代理人:
摘要：
An oral formulation can include an omega-3 fatty acid, a stilbenoid, a flavonoid, and vitamin D, each present in an amount and weight ratio that causes the formulation to mimic a gene expression profile of caloric restriction in a tissue of a subject, when administered to the subject in a therapeutically effective amount. The oral formulation can also be used in a method of mimicking a caloric restriction gene expression profile in a tissue of a subject.
